Prevention of Cardiovascular Stiffening With Aging and Hypertensive Heart Disease

Heart Failure, Diastolic Clinical Trial

— LVH  

Official title:

Prevention of Cardiovascular Stiffening With Aging and Hypertensive Heart Disease

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03476785
• Other study ID #: STU 062014-068
• Status: Completed
• Phase: N/A
• Start date: June 1, 2015
• Est. completion date: July 2, 2019

Study information

• Verified date: October 2019
• Source: University of Texas Southwestern Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine whether vigorous exercise training 4-5 days/week for one year in sedentary middle aged (ages 40-64) individuals at high risk for future development of heart failure will improve cardiac and vascular compliance to a degree equivalent to life-long exercisers and the sedentary young. To date, no effective therapy for heart failure with preserved ejection fraction (HFpEF) has been found; therefore prevention is critical and discovering novel treatment strategies is essential. Exercise training if implemented in high risk patients may improve diastolic function and cardiac-vascular interactions, preventing further progression to overt heart failure.

Description:

The global objective of this project is to test novel strategies to prevent diastolic dysfunction associated with HFpEF; these include: a) identifying high risk individuals by using population derived imaging and blood biomarkers; and b) implementing novel exercise training strategies in these middle age individuals, when cardiac plasticity still exists, to forestall the development of diastolic abnormalities that progress to HFpEF.

Prior research has demonstrated that: a) healthy but sedentary aging leads to atrophy and stiffening of the heart with reduced myocardial and chamber compliance; b) in contrast, highly competitive senior athletes had cardiac compliance that was indistinguishable from healthy young individuals suggesting that lifelong exercise training prevented this stiffening; c) even prolonged and intense exercise training started after age 65 failed to reverse age-related cardiac and vascular stiffening; d) cardiac stiffening begins in middle age (40-64) and can be substantially prevented by training 4-5 days/wk. The primary objective of this project is therefore to identify high risk sedentary individuals age 40-64, and initiate an exercise program carefully designed to maximize effects on cardiovascular compliance and function. Findings from this aim would have enormous public health significance and establish a novel, practical exercise training strategy designed to reverse cardiovascular stiffening.

Hypothesis:

Exercise training, when implemented 4-5 times/week over a prolonged period of time in sedentary high risk middle aged men and women, age 40-64 will improve cardiac and vascular compliance to a degree equivalent to life-long exercisers (and sedentary young);

Specific Aim:

To test the hypothesis, two groups of previously sedentary subjects, ages 40-64 at particularly high risk for HF will be studied for one year, with the following interventions: 1) subjects undergoing prolonged endurance/interval/strength exercise training; and 2) strength and flexibility /balance control. Subjects will be categorized as high risk and enrolled on the basis of elevated serum biomarkers and left ventricular hypertrophy (LVH) documented by cardiac MRI. Comprehensive invasive and non-invasive assessment of cardiovascular structure and systolic/diastolic function will be performed before and after 1 year of an exercise intervention involving high intensity aerobic intervals, lower intensity endurance training, and strength training, compared with strength and flexibility control.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 56
• Est. completion date: July 2, 2019
• Est. primary completion date: July 2, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 40 Years to 64 Years

Eligibility

Inclusion Criteria:

• Presence of left ventricular hypertrophy (by MRI, echocardiography or ECG)

• Normal ejection fraction (>50%)

• Elevated cardiac biomarker (high sensitivity troponin, NT-BNP)

Exclusion Criteria:

• age < 40 or >64

• body mass index>35

• history of heart failure, myocarditis, restrictive cardiomyopathy, severe chronic obstructive pulmonary disease, unstable coronary artery disease or recent (<12 month) acute coronary syndrome, cerebrovascular disease as evidenced by prior transient ischemic attack or stroke and active/recent tobacco use (quit < 5 years).

• chronic orthopedic injury that precludes exercise testing

Related Conditions & MeSH terms

• Heart Diseases
• Heart Failure, Diastolic
• Hypertrophy
• Lv Hypertrophy
• Stiffness, Vascular

Intervention

Behavioral:
• High intensity exercise
Subjects will perform high intensity aerobic exercise in addition to moderate intensity sessions 4-5 times per week.
• Yoga
Subjects will perform strength and flexibility exercises.

Locations

Country	Name	City	State
United States	The Institute for Exercise and Environmental Medicine	Dallas	Texas

Sponsors (1)

Lead Sponsor	Collaborator
University of Texas Southwestern Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Left ventricular stiffness	Change in ventricular stiffness after 1 year of exercise training measured as the stiffness constant of the diastolic limb of the left ventricular pressure-volume curve	1 year
Secondary	Aerobic fitness	Change in peak aerobic capacity (VO2) after 1 year of exercise training	1 year
Secondary	Vascular stiffness	Change in pulse wave velocity after 1 year of exercise training	1 year